76 related articles for article (PubMed ID: 2843483)
41. Age-related susceptibility to Pseudomonas aeruginosa ocular infections in mice.
Hazlett LD; Rosen DD; Berk RS
Infect Immun; 1978 Apr; 20(1):25-9. PubMed ID: 669795
[TBL] [Abstract][Full Text] [Related]
42. Effect of C3 depletion on experimental Pseudomonas aeruginosa ocular infection: histopathological analysis.
Hazlett LD; Berk RS
Infect Immun; 1984 Mar; 43(3):783-90. PubMed ID: 6698607
[TBL] [Abstract][Full Text] [Related]
43. The influence of vehicles on neomycin sulfate prevention of experimental ocular infection in rabbits.
Bach FC; Riddel G; Miller C; Martin JA; Mullins JD
Am J Ophthalmol; 1970 Apr; 69(4):659-62. PubMed ID: 4985570
[No Abstract] [Full Text] [Related]
44. Experimental Pseudomonas exotoxin A mediated ocular damage in mouse pups: microscopic observations.
Hazlett LD; Iglewski BH; Berk RS
Ophthalmic Res; 1982; 14(6):401-8. PubMed ID: 6819502
[TBL] [Abstract][Full Text] [Related]
45. PM
Somayajulu M; McClellan SA; Muhammed F; Wright R; Hazlett LD
Front Cell Infect Microbiol; 2023; 13():1240903. PubMed ID: 37868351
[TBL] [Abstract][Full Text] [Related]
46. Development of an anti-
Horspool AM; Sen-Kilic E; Malkowski AC; Breslow SL; Mateu-Borras M; Hudson MS; Nunley MA; Elliott S; Ray K; Snyder GA; Miller SJ; Kang J; Blackwood CB; Weaver KL; Witt WT; Huckaby AB; Pyles GM; Clark T; Al Qatarneh S; Lewis GK; Damron FH; Barbier M
Front Cell Infect Microbiol; 2023; 13():1117844. PubMed ID: 37124031
[TBL] [Abstract][Full Text] [Related]
47. Ocular Effects of Glycyrrhizin at Acidic and Neutral pH.
Somayajulu M; McClellan SA; Bessert DA; Pitchaikannu A; Hazlett LD
Front Cell Infect Microbiol; 2021; 11():782063. PubMed ID: 35127554
[TBL] [Abstract][Full Text] [Related]
48. Foundational concepts in the biology of bacterial keratitis.
Ung L; Chodosh J
Exp Eye Res; 2021 Aug; 209():108647. PubMed ID: 34097906
[TBL] [Abstract][Full Text] [Related]
49. High-mobility group box 1: a novel target for treatment of Pseudomonas aeruginosa keratitis.
McClellan S; Jiang X; Barrett R; Hazlett LD
J Immunol; 2015 Feb; 194(4):1776-87. PubMed ID: 25589066
[TBL] [Abstract][Full Text] [Related]
50. Immunoproteomics: the key to discovery of new vaccine antigens against bacterial respiratory infections.
Dennehy R; McClean S
Curr Protein Pept Sci; 2012 Dec; 13(8):807-15. PubMed ID: 23305366
[TBL] [Abstract][Full Text] [Related]
51. VIP and growth factors in the infected cornea.
Jiang X; McClellan SA; Barrett RP; Berger EA; Zhang Y; Hazlett LD
Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6154-61. PubMed ID: 21666233
[TBL] [Abstract][Full Text] [Related]
52. Animal models of bacterial keratitis.
Marquart ME
J Biomed Biotechnol; 2011; 2011():680642. PubMed ID: 21274270
[TBL] [Abstract][Full Text] [Related]
53. Protective anti-Pseudomonas aeruginosa humoral and cellular mucosal immunity by AdC7-mediated expression of the P. aeruginosa protein OprF.
Krause A; Whu WZ; Xu Y; Joh J; Crystal RG; Worgall S
Vaccine; 2011 Mar; 29(11):2131-9. PubMed ID: 21215829
[TBL] [Abstract][Full Text] [Related]
54. A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection.
Zaidi TS; Priebe GP; Pier GB
Infect Immun; 2006 Feb; 74(2):975-83. PubMed ID: 16428743
[TBL] [Abstract][Full Text] [Related]
55. Protection against P. aeruginosa with an adenovirus vector containing an OprF epitope in the capsid.
Worgall S; Krause A; Rivara M; Hee KK; Vintayen EV; Hackett NR; Roelvink PW; Bruder JT; Wickham TJ; Kovesdi I; Crystal RG
J Clin Invest; 2005 May; 115(5):1281-9. PubMed ID: 15841217
[TBL] [Abstract][Full Text] [Related]
56. Effector mechanisms of protection against Pseudomonas aeruginosa keratitis in immunized rats.
Thakur A; Kyd J; Xue M; Willcox MD; Cripps A
Infect Immun; 2001 May; 69(5):3295-304. PubMed ID: 11292752
[TBL] [Abstract][Full Text] [Related]
57. Kinetics of serum and ocular antibody responses in susceptible mice that received a secondary corneal infection with Pseudomonas aeruginosa.
Preston MJ; Kernack K; Berk RS
Infect Immun; 1993 Jun; 61(6):2713-6. PubMed ID: 8500912
[TBL] [Abstract][Full Text] [Related]
58. Rapid and sensitive method for evaluating Pseudomonas aeruginosa virulence factors during corneal infections in mice.
Preston MJ; Fleiszig SM; Zaidi TS; Goldberg JB; Shortridge VD; Vasil ML; Pier GB
Infect Immun; 1995 Sep; 63(9):3497-501. PubMed ID: 7642283
[TBL] [Abstract][Full Text] [Related]
59. Use of synthetic peptides to identify surface-exposed, linear B-cell epitopes within outer membrane protein F of Pseudomonas aeruginosa.
Gilleland HE; Hughes EE; Gilleland LB; Matthews-Greer JM; Staczek J
Curr Microbiol; 1995 Nov; 31(5):279-86. PubMed ID: 7580798
[TBL] [Abstract][Full Text] [Related]
60. Kinetics of serum, tear, and corneal antibody responses in resistant and susceptible mice intracorneally infected with Pseudomonas aeruginosa.
Preston MJ; Kernacki KA; Berk JM; Hazlett LD; Berk RS
Infect Immun; 1992 Mar; 60(3):885-91. PubMed ID: 1541561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
